In vitro and in vivo analysis of B-Myb in basal-like breast cancer (original) (raw)
Bergamaschi A, Kim YH, Wang P, Sørlie T, Hernandez-Boussard T, Lonning PE et al. (2006). Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes, Chromosomes Cancer45: 1033–1040. ArticleCASPubMed Google Scholar
Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F et al. (2007). The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res13: 2329–2334. ArticleCASPubMed Google Scholar
Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K et al. (2006). Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA295: 2492–2502. ArticleCASPubMed Google Scholar
Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo W-L et al. (2006). Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell10: 529–541. ArticleCASPubMed Google Scholar
Davidson CJ, Tirouvanziam R, Herzenberg LA, Lipsick JS . (2005). Functional evolution of the vertebrate Myb gene family: B-Myb, but neither A-Myb nor c-Myb, complements Drosophila Myb in hemocytes. Genetics169: 215–229. ArticleCASPubMedPubMed Central Google Scholar
Derenzini M, Donati G, Mazzini G, Montanaro L, Vici M, Ceccarelli C et al. (2008). Loss of retinoblastoma tumor suppressor protein makes human breast cancer cells more sensitive to antimetabolite exposure. Clin Cancer Res14: 2199–2209. ArticleCASPubMed Google Scholar
Herschkowitz JI, He X, Fan C, Perou CM . (2008). The functional loss of the retinoblastoma tumor suppressor is a common event in basal-like and luminal B breast carcinomas. Breast Cancer Res10: R75. ArticlePubMedPubMed Central Google Scholar
Hess KR, Anderson K, Symmans WF, Valero V, Ibrahim N, Mejia JA et al. (2006). Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. J Clin Oncol24: 4236–4244. ArticleCASPubMed Google Scholar
Hoadley K, Weigman V, Fan C, Sawyer L, He X, Troester M et al. (2007). EGFR associated expression profiles vary with breast tumor subtype. BMC Genomics8: 258. ArticlePubMedPubMed Central Google Scholar
Hosack DA, Dennis Jr G, Sherman BT, Lane HC, Lempicki RA . (2003). Identifying biological themes within lists of genes with EASE. Genome Biol4 (10): R70. ArticlePubMedPubMed Central Google Scholar
Hu Z, Fan C, Oh D, Marron J, He X, Qaqish B et al. (2006). The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics7: 96. ArticlePubMedPubMed Central Google Scholar
Hu Z, Troester MA, Perou CM . (2005). High reproducibility using sodium hydroxide-stripped long oligonucleotide DNA microarrays. Biotechniques38: 121–124. ArticleCASPubMed Google Scholar
Ito M, Araki S, Matsunaga S, Itoh T, Nishihama R, Machida Y et al. (2001). G2/M-phase-specific transcription during the plant cell cycle is mediated by c-Myb-like transcription factors. Plant Cell13: 1891–1905. ArticleCASPubMedPubMed Central Google Scholar
Klempnauer K-H, Gonda TJ, Bishop MJ . (1982). Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene. Cell31: 453–463. ArticleCASPubMed Google Scholar
Leprince D, Gegonne A, Coll J, de Taisne C, Schneeberger A, Lagrou C et al. (1983). A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature306: 395. ArticleCASPubMed Google Scholar
Malaterre J, Carpinelli M, Ernst M, Alexander W, Cooke M, Sutton S et al. (2007). c-Myb is required for progenitor cell homeostasis in colonic crypts. Proc Natl Acad Sci USA104: 3829–3834. ArticleCASPubMedPubMed Central Google Scholar
Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A et al. (2005). An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci102: 13550–13555. ArticleCASPubMedPubMed Central Google Scholar
Millikan R, Eaton A, Worley K, Biscocho L, Hodgson E, Huang W-Y et al. (2003). HER2 codon 655 polymorphism and risk of breast cancer in African Americans and Whites. Breast Cancer Res Treat79: 355. ArticleCASPubMed Google Scholar
Millikan RC, Newman B, Tse C-K, Moorman PG, Conway K, Smith K et al. (2008). Epidemiology of basal-like breast cancer. Breast Cancer Res Treat109: 123–139. ArticlePubMed Google Scholar
Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA et al. (1991). A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell65: 677. ArticleCASPubMed Google Scholar
Ness SA . (2003). Myb protein specificity: evidence of a context-specific transcription factor code. Blood Cells Mol Dis31: 192. ArticleCASPubMed Google Scholar
Newman B, Moorman P, Millikan R, Qaqish B, Geradts J, Aldrich T et al. (1995). The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat35: 51–60. ArticleCASPubMed Google Scholar
Nomura N, Takahashi M, Matsui M, Ishii S, Date T, Sasamoto S et al. (1988). Isolation of human cDNA clones of myb-related genes, A-myb and B-myb. Nucleic Acids Res16: 11075–11089. ArticleCASPubMedPubMed Central Google Scholar
Osterloh L, vonEyss B, Schmit F, Rein L, Hübner D, Samans B et al. (2007). The human synMuv-like protein LIN-9 is required for transcription of G2/M genes and for entry into mitosis. EMBO J26: 144–157. ArticleCASPubMed Google Scholar
Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al. (2000). Molecular portraits of human breast tumours. Nature406: 747. ArticleCASPubMed Google Scholar
Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME et al. (2002). Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature415: 436. ArticleCASPubMed Google Scholar
Rosinski JA, Atchley WR . (1998). Molecular evolution of the Myb family of transcription factors: evidence for polyphyletic origin. J Mol Evol46: 74–83. ArticleCASPubMed Google Scholar
Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K et al. (2005). Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res11: 5678–5685. ArticleCASPubMed Google Scholar
Sala A . (2005). B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer. Eur J Cancer41: 2479–2484. ArticleCASPubMed Google Scholar
Schwab R, Bussolari R, Corvetta D, Chayka O, Santilli G, Kwok JMM et al. (2007). Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk. Oncogene27: 2929–2933. ArticlePubMed Google Scholar
Smith P, Soues S, Gottlieb T, Falk S, Watson J, Osborne R et al. (1994). Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells. Br J Cancer70: 914–921. ArticleCASPubMedPubMed Central Google Scholar
Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H et al. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA98: 10869–10874. ArticleCASPubMedPubMed Central Google Scholar
Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A et al. (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA100: 8418–8423. ArticleCASPubMedPubMed Central Google Scholar
Tanaka Y, Patestos NP, Maekawa T, Ishii S . (1999). B-myb is required for inner cell mass formation at an early stage of development. J Biol Chem274: 28067–28070. ArticleCASPubMed Google Scholar
Toscani A, Mettus RV, Coupland R, Simpkins H, Litvin J, Orth J et al. (1997). Arrest of spermatogenesis and defective breast development in mice lacking A-myb. Nature386: 713. ArticleCASPubMed Google Scholar
Trauth K, Mutschler B, Jenkins N, Gilbert D, Copeland N, Klempnauer K . (1994). Mouse A-myb encodes a trans-activator and is expressed in mitotically active cells of the developing central nervous system, adult testis and B lymphocytes. EMBO J13: 5994–6005. ArticleCASPubMedPubMed Central Google Scholar
Troester MA, Hoadley KA, Sorlie T, Herbert B-S, Borresen-Dale A-L, Lonning PE et al. (2004). Cell-type-specific responses to chemotherapeutics in breast cancer. Cancer Res64: 4218–4226. ArticleCASPubMed Google Scholar
Tusher VG, Tibshirani R, Chu G . (2001). Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA98: 5116–5121. ArticleCASPubMedPubMed Central Google Scholar
van de Vijver MJ, He YD, van ‘t Veer LJ, Dai H, Hart AAM, Voskuil DW et al. (2002). A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med347: 1999–2009. ArticleCASPubMed Google Scholar
Vanewijk PH, Hoekstra JA . (1993). Calculation of the EC50 and its confidence interval when subtoxic stimulus is present. Ecotoxicol Environ Saf25: 25. ArticleCAS Google Scholar
Wang Y, Klijn JGM, Zhang Y, Sieuwerts AM, Look MP, Yang F et al. (2005). Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet365: 671. ArticleCASPubMed Google Scholar
Whitfield ML, George LK, Grant GD, Perou CM . (2006). Common markers of proliferation. Nat Rev Cancer6: 99–106. ArticleCASPubMed Google Scholar
Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, Alexander KE et al. (2002). Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell13: 1977–2000. ArticleCASPubMedPubMed Central Google Scholar